ENHANCING EFFECT OF COMBINING 2 PYRROLIDONE VEHICLES ON TRANSDERMAL DRUG DELIVERY

被引:13
作者
SASAKI, H
KOJIMA, M
NAKAMURA, J
SHIBASAKI, J
机构
[1] Faculty of Pharmaceutical Sciences, Nagasaki University, Nagasaki, 852
关键词
D O I
10.1111/j.2042-7158.1990.tb05385.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Abstract— The enhancing effect of combining 1‐methyl‐2‐pyrrolidone (MP) and 1‐lauryl‐2‐pyrrolidone (LP) as the vehicles for transdermal penetration of phenolsulphonphthalein (phenol red) has been investigated by using an in‐vitro technique with excised rat skin. LP had a higher enhancing effect on the penetration of phenol red than MP, but there was a long lag time before steady‐state penetration was attained. A potent effect with a shorter lag time was obtained when MP and LP were used together. This potentiation was maintained when the concentration of MP was decreased by 95%. The combined vehicle also enhanced the skin accumulation of phenol red. MP promoted the rapid penetration of LP into the skin and potentiated the enhancing effect of LP on the penetration of phenol red and thereby shortened the lag time. The combined vehicle also enhanced the penetration of the hydrophilic anticancer agent, 5‐fluorouracil. 1990 Royal Pharmaceutical Society of Great Britain
引用
收藏
页码:196 / 199
页数:4
相关论文
共 24 条
[1]  
BARRY BW, 1983, DERMATOLOGICAL FORMU, P127
[2]   OPTIMIZATION OF BIOAVAILABILITY OF TOPICAL STEROIDS - NON-OCCLUDED PENETRATION ENHANCERS UNDER THERMODYNAMIC CONTROL [J].
BENNETT, SL ;
BARRY, BW ;
WOODFORD, R .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (05) :298-304
[3]   ETHANOL - WATER MUTUALLY ENHANCED TRANSDERMAL THERAPEUTIC SYSTEM .1. NITROGLYCERIN SOLUTION PROPERTIES AND MEMBRANE-TRANSPORT [J].
BERNER, B ;
OTTE, JH ;
MAZZENGA, GC ;
STEFFENS, RJ ;
EBERT, CD .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (04) :314-318
[4]   ETHANOL WATER MUTUALLY ENHANCED TRANSDERMAL THERAPEUTIC SYSTEM .2. SKIN PERMEATION OF ETHANOL AND NITROGLYCERIN [J].
BERNER, B ;
MAZZENGA, GC ;
OTTE, JH ;
STEFFENS, RJ ;
JUANG, RH ;
EBERT, CD .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (05) :402-407
[5]   LOGICS OF TRANSDERMAL CONTROLLED DRUG ADMINISTRATION [J].
CHIEN, YW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1983, 9 (04) :497-520
[6]  
HADGRAFT J, 1984, PHARM INT, V5, P252
[7]  
HOELGAARD A, 1985, Journal of Controlled Release, V2, P111, DOI 10.1016/0168-3659(85)90037-9
[8]   PERCUTANEOUS ABSORPTION [J].
IDSON, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (06) :901-924
[9]   EFFECTS OF 5-FLUOROURACIL (5-FU) OINTMENT IN TREATMENT OF NEOPLASTIC DERMATOSES [J].
KLEIN, E ;
STOLL, HL ;
MILLER, E ;
MILGROM, H ;
HELM, F ;
BURGESS, G .
DERMATOLOGICA, 1970, 140 :21-+
[10]   IMPROVED DELIVERY THROUGH BIOLOGICAL-MEMBRANES .10. PERCUTANEOUS-ABSORPTION AND METABOLISM OF METHYLSULFINYLMETHYL 2-ACETOXYBENZOATE AND RELATED ASPIRIN PRODRUGS [J].
LOFTSSON, T ;
BODOR, N .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (07) :756-758